Literature DB >> 31663926

Staged Bilateral Total Knee Arthroplasty: Increased Risk of Recurring Complications.

Trevor R Grace1, Ellen L Tsay2, Heather J Roberts1, Thomas P Vail1, Derek T Ward1.   

Abstract

BACKGROUND: As the demand for knee arthroplasty increases, risk assessment and counseling are critical for optimal patient outcomes perioperatively. The purpose of this study was to determine if specific complications occurring after unilateral knee replacement predict the risk of recurrence after a staged replacement of the contralateral knee for patients with bilateral symptomatic disease.
METHODS: Linked, nationwide data from the U.S. Hospital Cost and Utilization Project from 2005 to 2014 were used to measure the occurrence of complications after the first and second procedures in staged bilateral total knee arthroplasties (TKAs). Odds ratios (ORs) and conditional probabilities were determined to assess whether having a specific complication after the first TKA increased the chance that the same complication occurred after the second procedure.
RESULTS: A total of 36,278 patients who underwent staged bilateral TKAs were analyzed. All complications occurring after the first arthroplasty were associated with both a significantly increased probability and odds of recurrence following the second arthroplasty. These included myocardial infarction (OR, 56.63 [95% confidence interval (CI), 18.04 to 155.44]; p < 0.001), ischemic stroke (OR, 41.38 [95% CI, 1.98 to 275.82]; p = 0.03), other cardiac complications (OR, 7.73 [95% CI, 4.24 to 14.11]; p < 0.001), respiratory complications (OR, 8.58 [95% CI, 2.85 to 23.17]; p = 0.002), urinary complications (OR, 11.19 [95% CI, 5.44 to 22.25]; p = 0.001), hematoma (OR, 15.05 [95% CI, 7.90 to 27.27]; p < 0.001), deep vein thrombosis (OR, 7.40 [95% CI, 5.37 to 10.08]; p < 0.001), and pulmonary embolism (OR, 11.00 [95% CI, 5.01 to 23.92]; p < 0.001).
CONCLUSIONS: Medical complications that occur postoperatively after TKA are associated with a significantly increased risk of recurrence of these complications after staged replacement of the contralateral knee. Although overall complication rates remain low, patients who develop these medical complications after the first replacement should be counseled on their increased risk profile prior to the contralateral surgical procedure. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Year:  2020        PMID: 31663926     DOI: 10.2106/JBJS.19.00243

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  5 in total

Review 1.  Medium-term outcomes in single anaesthetic bilateral total knee replacement surgery: a single surgeon series.

Authors:  M J Kelly; J F Quinlan; C Frampton; J A Matheson
Journal:  Arch Orthop Trauma Surg       Date:  2021-09-08       Impact factor: 2.928

2.  Clinical outcomes of simultaneous bilateral total knee arthroplasty.: A tertiary-center experience.

Authors:  Abdullah O Bawazir; Hossein A Filimban; Nawaf Halabi; Salman W Bafageeh; Rayan Halabi; Saeed Albukhari; Eyad A Alakkas; Habib Al Etani; Abdullah Basalaim; Ahmed Alturkistan; Bander Hetaimish
Journal:  Saudi Med J       Date:  2022-03       Impact factor: 1.422

3.  Simultaneous bilateral total knee arthroplasty : similar outcomes for trainees and trainers.

Authors:  Gerard A Sheridan; Rotem Moshkovitz; Bassam A Masri
Journal:  Bone Jt Open       Date:  2022-01

4.  Simultaneous Bilateral Total Knee Arthroplasty in Elderly: Are There Factors that Can Influence Safety and Clinical Outcome?

Authors:  G Piovan; D Screpis; S Natali; V Iacono; M Baldini; L Farinelli; M Guerriero; C Zorzi
Journal:  Adv Orthop       Date:  2022-08-21

5.  Obesity and its effect on outcomes in same-day bilateral total knee arthroplasty.

Authors:  Ethan A Remily; Nequesha S Mohamed; Wayne A Wilkie; Tyler Smith; Anthony Judice; Salvador Forte; James Nace; Ronald E Delanois
Journal:  Ann Transl Med       Date:  2020-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.